Bespoke Extracts (BSPK) Enterprise Value (2011 - 2025)
Bespoke Extracts (BSPK) reported Enterprise Value of -$16743.0 for Q3 2025, up 21.93% on a YoY basis from -$13732.1 in Q3 2024, and down 1128.39% sequentially from -$1363.0 in Q2 2025.
Bespoke Extracts (BSPK) Enterprise Value (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Enterprise Value data on file, last reported at -$16743.0 in Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value rose 21.93% year-over-year to -$16743.0; the trailing twelve-month figure through Sep 2025 stood at -$16743.0 (up 21.93% YoY), and the FY2024 full-year result was -$60305.0, down 812.74% from the prior year.
- Enterprise Value slipped to -$16743.0 in Q3 2025, from -$1363.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1363.0 in Q2 2025 to a low of -$501560.0 in Q1 2021.
- A 5-year average of -$53842.3 and a median of -$22150.5 in 2022 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 97.56% in 2021, while the deepest fall reached 27522.92% in 2021.
- Tracing BSPK's Enterprise Value over 5 years: stood at -$6295.0 in 2021, then plunged by 288.13% to -$24433.0 in 2022, then surged by 72.96% to -$6607.0 in 2023, then slumped by 812.74% to -$60305.0 in 2024, then jumped by 72.24% to -$16743.0 in 2025.
- Business Quant data shows BSPK's Enterprise Value at -$16743.0 in Q3 2025, -$1363.0 in Q2 2025, and -$30365.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | -16,743.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -16,743.00 |
| Jun 30, 2025 | -1,363.00 |
| Mar 31, 2025 | -30,365.00 |
| Dec 31, 2024 | -60,305.00 |
| Sep 30, 2024 | -21,445.00 |
| Jun 30, 2024 | -24,791.00 |
| Mar 31, 2024 | -14,416.00 |
| Dec 31, 2023 | -6,607.00 |
| Jun 30, 2023 | -1,947.00 |
| Mar 31, 2023 | -4,365.00 |
| Dec 31, 2022 | -24,433.00 |
| Sep 30, 2022 | -22,856.00 |
| Jun 30, 2022 | -36,574.00 |
| Mar 31, 2022 | -100,774.00 |
| Nov 30, 2021 | -6,295.00 |
| Aug 31, 2021 | -11,177.00 |
| May 31, 2021 | -83,145.00 |
| Feb 28, 2021 | -501,560.00 |
| Nov 30, 2020 | -258,246.00 |
| Aug 31, 2020 | -126,603.00 |